International Strategies for Tropical Disease Treatments - Experiences with Praziquantel - EDM Research Series No. 026
(1998; 113 pages) View the PDF document
Table of Contents
View the documentAbstract
View the documentAcknowledgments
View the documentInformation on authors
View the documentExchange rates used in the report
Close this folderChapter 1: Policies for praziquantel*
View the documentObjectives of this report
View the documentStructure of the report
View the documentLessons learned
View the documentReferences
Open this folder and view contentsChapter 2: Bayer & E. Merck: Discovery and development of praziquantel*
Open this folder and view contentsChapter 3: Shin Poong Pharmaceutical Co.: Process development in the Republic of Korea*
Open this folder and view contentsChapter 4: The Egyptian International Pharmaceutical Industries Co.: Praziquantel formulation*
Open this folder and view contentsChapter 5: The international supply of praziquantel*
Open this folder and view contentsChapter 6: Demand for praziquantel and national distribution*
Open this folder and view contentsChapter 7: Prices and production costs of praziquantel*
View the documentOther documents in the DAP Research Series
View the documentDAP Research Series No. 26


Alford, William P., To Steal a Book is an Elegant Offense: Intellectual Property Law in Chinese Civilization, Stanford: Stanford University Press, 1995.

Drabek, A.G., “Development Alternatives: The Challenge for NGOs-An Overview of the Issues,” World Development 15(suppl.):9-15, 1987.

The Economist, “Trade Tripwires,” August 27, 1994:61.

Grady, C., The Search for an AIDS Vaccine: Ethical Issues in the Development and Testing of a New HIV Vaccine. Bloomington: Indiana University Press, 1995.

Hunter, J.M., L. Rey, K.Y. Chu, E.O. Adekolu-John, and K.E. Mott, Parasitic Diseases in Water Resources Development: The Need for Intersectoral Negotiation. Geneva: World Health Organization, 1993.

Rapp, Richard, and Richard Rozek, “Benefits and Costs of Intellectual Property Protection in Developing Countries,” Journal of World Trade 24:75-102, 1990.

Reich, Michael R., “The Political Economy of Health Transitions in the Third World,” in L.C. Chen, A. Kleinman, and N.C. Ware, eds., Health and Social Change in International Perspective, Boston: Harvard School of Public Health, 1994:413-451.

Weiss, S., Merck & Co., Inc., Case no. 90-013. Stanford, CA: The Business Enterprise Trust, 1991.

Wolf, Charles, Markets or Governments: Choosing Between Imperfect Alternatives, Cambridge, MA: MIT Press, 1988.

World Bank, World Development Report 1993: Investing in Health, New York: Oxford University Press, 1993.

WHO Task Force on Health Economics, WTO: What’s in it for WHO?, Geneva: World Health Organization, 1995.


to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017